Trending Stock News

Cam Group Holding A Decreased Its Boston Scientific (BSX) Position by $414,062; Valuation Rose; Westwood Holdings Group Lowered Stake in Bb&T (BBT) as Shares Declined

Westwood Holdings Group Inc decreased its stake in Bb&T Corp (BBT) by 1.02% based on its latest 2017Q3 regulatory filing with the SEC. Westwood Holdings Group Inc sold 17,840 shares as the company’s stock declined 11.91% while stock markets rallied. The institutional investor held 1.72M shares of the major banks company at the end of 2017Q3, valued at $80.96M, down from 1.74 million at the end of the previous reported quarter. Westwood Holdings Group Inc who had been investing in Bb&T Corp for a number of months, seems to be less bullish one the $41.92B market cap company. The stock decreased 0.04% or $0.02 during the last trading session, reaching $53.14. About 4.42 million shares traded. BB&T Corporation (NYSE:BBT) has risen 20.68% since January 14, 2017 and is uptrending. It has outperformed by 3.98% the S&P500.

Cam Group Holding A decreased its stake in Boston Scientific Corp (BSX) by 3.74% based on its latest 2017Q3 regulatory filing with the SEC. Cam Group Holding A sold 14,278 shares as the company’s stock rose 4.02% with the market. The institutional investor held 367,194 shares of the medical and dental instruments company at the end of 2017Q3, valued at $10.71M, down from 381,472 at the end of the previous reported quarter. Cam Group Holding A who had been investing in Boston Scientific Corp for a number of months, seems to be less bullish one the $37.71 billion market cap company. The stock increased 0.11% or $0.03 during the last trading session, reaching $27.46. About 8.75M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since January 14, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Cam Group Holding A, which manages about $7.04 billion US Long portfolio, upped its stake in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 15,301 shares to 64,042 shares, valued at $3.82 million in 2017Q3, according to the filing. It also increased its holding in First Rep Bk San Francisco C (NYSE:FRC) by 64,663 shares in the quarter, for a total of 3.22M shares, and has risen its stake in Vertex Pharmaceuticals Inc (NASDAQ:VRTX).

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 83 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Hold” rating by Oppenheimer on Wednesday, June 28. On Friday, July 29 the stock rating was maintained by Needham with “Buy”. The rating was maintained by Jefferies with “Hold” on Friday, July 29. RBC Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) on Friday, September 1 with “Buy” rating. The stock of Boston Scientific Corporation (NYSE:BSX) has “Hold” rating given on Friday, October 6 by Jefferies. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by RBC Capital Markets on Sunday, November 5. Cowen & Co maintained Boston Scientific Corporation (NYSE:BSX) on Wednesday, November 29 with “Buy” rating. Oppenheimer maintained it with “Hold” rating and $2900 target in Friday, July 28 report. The stock of Boston Scientific Corporation (NYSE:BSX) has “Outperform” rating given on Friday, June 9 by RBC Capital Markets. As per Thursday, February 25, the company rating was initiated by Suntrust Robinson.

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on February, 1. They expect $0.34 earnings per share, up 13.33% or $0.04 from last year’s $0.3 per share. BSX’s profit will be $466.89 million for 20.19 P/E if the $0.34 EPS becomes a reality. After $0.31 actual earnings per share reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 9.68% EPS growth.

Since August 1, 2017, it had 0 insider buys, and 13 insider sales for $15.16 million activity. Phalen Michael P. sold $416,559 worth of stock. Bose Supratim sold 347,137 shares worth $10.11M. Nanavaty Maulik sold $1.56 million worth of Boston Scientific Corporation (NYSE:BSX) on Wednesday, August 30. 8,763 shares were sold by Pierce David A, worth $243,074 on Thursday, January 11. Shares for $332,584 were sold by Carruthers Wendy on Thursday, August 3. The insider Sorenson John Bradley sold 7,900 shares worth $208,328.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It improved, as 33 investors sold BSX shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. First Retail Bank Of Omaha holds 0.35% in Boston Scientific Corporation (NYSE:BSX) or 194,097 shares. Spc Financial holds 35,073 shares. Moneta Gru Invest Advsr Lc accumulated 10,440 shares or 0.05% of the stock. Prudential Public Ltd Company has invested 0% in Boston Scientific Corporation (NYSE:BSX). Redwood Invs Ltd Liability Corp, a Massachusetts-based fund reported 259,120 shares. Salem Invest Counselors stated it has 0.43% in Boston Scientific Corporation (NYSE:BSX). Primecap Mgmt Ca has 42.17 million shares for 1.02% of their portfolio. Deroy & Devereaux Private Inv Counsel reported 2.07% stake. Virginia-based Thompson Davis & Company has invested 0.53% in Boston Scientific Corporation (NYSE:BSX). Van Cleef Asset Managementinc reported 9,400 shares. Diamond Hill Cap Management has 0.46% invested in Boston Scientific Corporation (NYSE:BSX) for 3.01M shares. Yhb Inv Advsrs accumulated 9,020 shares or 0.05% of the stock. Schroder Management Grp holds 0.01% or 253,421 shares. Gateway Investment Advisers Limited Liability Company reported 0.3% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Ontario Teachers Pension Plan Board reported 272,371 shares stake.

Analysts await BB&T Corporation (NYSE:BBT) to report earnings on January, 18 before the open. They expect $0.80 earnings per share, up 9.59% or $0.07 from last year’s $0.73 per share. BBT’s profit will be $631.13 million for 16.61 P/E if the $0.80 EPS becomes a reality. After $0.78 actual earnings per share reported by BB&T Corporation for the previous quarter, Wall Street now forecasts 2.56% EPS growth.

Investors sentiment decreased to 0.93 in 2017 Q3. Its down 0.23, from 1.16 in 2017Q2. It is negative, as 56 investors sold BBT shares while 291 reduced holdings. 81 funds opened positions while 241 raised stakes. 500.82 million shares or 2.15% less from 511.81 million shares in 2017Q2 were reported. Franklin Street Advsr Nc owns 0.25% invested in BB&T Corporation (NYSE:BBT) for 32,071 shares. 7,309 were reported by Birmingham Management Com Al. Tokio Marine Asset Mgmt Ltd owns 7,679 shares. Cape Cod Five Cents Bankshares invested in 0.81% or 111,693 shares. Moreover, First Allied Advisory Ser Incorporated has 0.03% invested in BB&T Corporation (NYSE:BBT) for 14,919 shares. North Star Investment Mgmt invested 0.03% of its portfolio in BB&T Corporation (NYSE:BBT). New Mexico Educational Retirement Board invested in 75,466 shares. Kbc Gp Nv holds 93,686 shares. Fjarde Ap has invested 0.18% in BB&T Corporation (NYSE:BBT). Wells Fargo & Co Mn has invested 0.09% in BB&T Corporation (NYSE:BBT). Stephens Ar reported 94,455 shares. Opus Cap holds 0.25% in BB&T Corporation (NYSE:BBT) or 23,865 shares. Plante Moran Financial Ltd holds 0.01% or 210 shares in its portfolio. Gamble Jones Invest Counsel holds 0.05% or 10,872 shares in its portfolio. State Of Alaska Department Of Revenue holds 0.09% of its portfolio in BB&T Corporation (NYSE:BBT) for 38,238 shares.

Since August 16, 2017, it had 0 insider purchases, and 7 sales for $7.30 million activity. Shares for $2.01M were sold by Henson Christopher L. BANNER JENNIFER S sold $559,259 worth of stock. 12,357 shares were sold by Johnson Robert Jerome JR, worth $589,373 on Wednesday, October 25. Another trade for 8,752 shares valued at $410,539 was made by Weaver David Hudson on Wednesday, August 16. $3.15 million worth of BB&T Corporation (NYSE:BBT) was sold by KING KELLY S on Friday, October 20. Wilson Donta L sold $201,929 worth of stock or 4,250 shares.

Westwood Holdings Group Inc, which manages about $12.59B US Long portfolio, upped its stake in Illinois Tool Wks Inc (NYSE:ITW) by 7,926 shares to 38,321 shares, valued at $5.67 million in 2017Q3, according to the filing. It also increased its holding in Zoetis Inc (NYSE:ZTS) by 16,631 shares in the quarter, for a total of 57,501 shares, and has risen its stake in Carriage Services Inc (NYSE:CSV).

Among 30 analysts covering BB&T Corp (NYSE:BBT), 10 have Buy rating, 0 Sell and 20 Hold. Therefore 33% are positive. BB&T Corp had 86 analyst reports since July 17, 2015 according to SRatingsIntel. The stock of BB&T Corporation (NYSE:BBT) has “Buy” rating given on Monday, January 23 by Hilliard Lyons. The rating was maintained by Wells Fargo on Thursday, August 10 with “Market Perform”. The stock of BB&T Corporation (NYSE:BBT) has “Neutral” rating given on Wednesday, January 11 by UBS. The stock of BB&T Corporation (NYSE:BBT) has “Hold” rating given on Tuesday, October 31 by Robert W. Baird. Morgan Stanley downgraded BB&T Corporation (NYSE:BBT) on Monday, November 14 to “Underweight” rating. SunTrust maintained BB&T Corporation (NYSE:BBT) rating on Monday, January 8. SunTrust has “Buy” rating and $59.0 target. RBC Capital Markets maintained BB&T Corporation (NYSE:BBT) rating on Thursday, July 27. RBC Capital Markets has “Buy” rating and $5000 target. The stock has “Buy” rating by RBC Capital Markets on Thursday, June 22. Deutsche Bank maintained it with “Hold” rating and $39 target in Tuesday, April 5 report. The firm earned “Neutral” rating on Monday, July 11 by Robert W. Baird.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *